Human Gene Patenting While researching texts written about genes the most interesting topic that came up was human gene patenting. Gene patenting is the exclusive right to a specific sequence of DNA given by a government to the individual , organization or corporation who claims to have first identified the gene. Human gene patenting is one of hot topic in today’s world and it could have a major effect for generations to come. Gene patenting represents a contract between an inventor and society. The goal in this paper to explain some of the benefits and risks involved in gene patenting. To achieve this goal, the paper has been organized into four sections. The first section discusses what gene patenting is and some of the events that took place prior to gene patenting. The second section includes some of the benefits of having a gene patent and how it can help people with some diseases. The third section explains the risks of having a gene patent. Some of the companies that hold patents and do nothing will impact people who need help. In the last section discusses what could be done to improve gene patenting and how it will help humanity. Before staring the paper a historical context is provided so one can understand how it all started.
Historical Context It all started with a women name Henrietta Lacks. An African American women who died because of cervical cancer in 1951. Cells were taken from her while she was alive and they were taken without her consent or any
Gregory Stock, in his article Choosing Our Genes, asserts that at this point not ethics are important, but rather the future of genetic technology. Stock supports his conclusion by providing powerful examples of how genetic modifications can benefit our population anywhere from correcting genes at the time of conception to extending lifespan. He wants to inform his audience about all of the benefits of genetic technology in order to prove that there are way more advantages in this technology that are highly desirable by people of different ages. He reaches his readers by writing a very detailed yet coherent article that brings awareness to various groups of people from parents to be to older populations.
In “Patenting Life,” Michael Crichton argues that the government is mishandling the patenting office with the awarding of patents for human genes. Gene patenting is blocking the advancement of modern medicine and could be costing many patients their lives. The hold on research results in the discovery of fewer cures for modern diseases.
In the two and a half decades of research that was done on HeLa cells from the 1950s through mid-1970s, no thought was given regarding the family of the woman whose cells were being utilized in such diverse ways. Then things changed, due in part to a discovery regarding the invasiveness of the cells and the presence of an enzyme which is only found in certain gene pools. Because scientists wished to study the genetics of the Lack family, they contacted members to ask for blood samples, whereupon it was revealed that Henrietta’s cells were alive and well and being used for the greater good of the scientific community. The family then began to make their own inquires about what had been done with the cells from Henrietta, which were harvested without her consent.
I really enjoyed your post as I did not know it was possible to patent a gene. I really liked the examples you gave as it helped me understand what it means for a gene to be patent and what it affects it can have on the patient and their family. I believe this is something that should not be legal as if someone else can find a cure for diseases instead of the organization who owns it they should be allowed to do so.
Patent Genes have been the center of a attention for a very long time. When we take the time to stop and think about how research and medical cost affect our lifestyles, it is very alarming to know that even the natural occurrences in life can be bought for the right price. In the op-ed piece and article, “Patenting Life” and “Decoding the Use of Gene Patents”, by Michael Crichton and John E. Calfee, both authors draw attention to the uses of patenting genes. Crichton goes on to say how gene patents have interfered with medical testings, research studies, and the miscommunications between doctors and their patients, while Calfee reiterates how patients and researchers are getting the benefits that come from patenting genes. Although both authors
Genetic Engineering has produced an array of breakthroughs in the progression of modern medicine. Though it is faced with both ethical and potential environmental grievances, the efficacious results of Genetic Engineering counterpoise the criticisms from environmentalists. Researchers in genetics have provided simple solutions to problems that society has consistently endured. Genetic Engineering offers solutions to failing crops and heightened yields in production as well as numerous applications in medicine. It is approached by the concerns of the environmental impact of such actions, as well as the civil concern on ethics.
“One-fifth of the genes in your body are privately owned” according to an author Michael Crichton. Can you imagine a corporate company owning your genes in your body? It’s called gene patenting and its real. Michael Crichton and John E. Calfee discuss gene patent. Although the authors agree that medical test are expensive due gene patenting, the authors have different views about nature patenting and medical advancement.
In order to continue surviving as a company, Myriad Genetics must gain some upper hand. They accomplished that by patenting the gene. To get their company started, Myriad needed financial support from private companies. Private companies would not fund a smaller company unless they were different and superior in some way. Myriad’s patent gave them just the control they needed to be seen as fundable. From this example, I want to emphasize how gene patents help scientific growth. If patents on genes were not available, companies like Myriad Genetics would not be able to stand out in a crowd of many gene researchers. People like to be rewarded for what they do, but if the chance of being rewarded for your years of hard work and money are very slim, then scientists may not be
In 1951, Henrietta Lacks was diagnosed with cervical cancer at John Hopkins and while under anesthesia, two pieces of cervical tissue were taken without her consent for medical research. Using the cells from Lack’s Tumor, Doctor George Gey, created the first “immortal” cell line called “Hela”. These cells are to this day the world’s most commonly used human cell. Now the main issue of this case was that Lacks had no idea that they took some of her tissue and neither did her family. Her family didn’t learn anything about the use of her cells for over 20 years. In 2010, author Rebecca Skloot wrote a book titled “The Immortal Life of Henrietta Lacks”, that focused on how the research establishment treated Lacks family. It was seen as unethical of the research establishment not to have asked permission or at least informed her family about the use of Lack’s cells. We see in this case a lack of informed consent. Should the family have a right of ownership on Lacks cells? Should they also profit from
Imagine this you're a scientist about to make a groundbreaking discovery finding the gene to cure HIV but, you get hit with a lawsuit because a gene was previously patented. All research is stopped by law and due to the patent you give up your research and if that is not enough you have to pay over $3,000 in royalties which leads to giving up on the project. “Patenting Life” (2007) writer Michael Crichton,, a well educated man in the medical field earning his degree from Harvard Medical School,, is trying to end yet, on the other hand “Decoding the Use of Gene Patents” (2009) John E. Calfee an economist believes Gene Patents are beneficiary and not harmful. Crichton and Calfee disagree in many ways being halt on research, worrying about a
The Dr.’s view on gene patents is the halt they put on testing and studying of genes and current studies to find a major breakthrough for the disease. (441) It is not only fair to the researchers who spend their lives trying to develop a cure but also to the loved ones and
Gene Patents seem to have a big impact on many people just like everything else going on around us. Many agree and others disagree on the fact that gene patents are owned. Michael Crichton explains how gene patents have an impact on people medically contrasting but also comparing to John E. Calfee who explains his view on gene patents economically. The Doctor and the Economist approach the topic on gene patents by acknowledging the subject, rights, and the costs.
The patenting issue gained some attention when President Bill Clinton and Prime Minster Tony Blair jointly called for the release of raw genetic data into the public domain (CQ 405). I will argue in this paper that the aggressive competition among biotechnology firms to patent genes is
Exploration into the function of each gene discovered will continue well into the 21st century. The knowledge gained from this will lead us to better understand the cause of genetically related diseases. Having the ability to recognize the causation of a disease will shift technology from trial and error treatments to specific drugs designed to treat the gene sequence and protein structure. This is called gene therapy and is the most exciting aspect of the HGP. It gives the
Every living thing is the product of the genes that were passed down from ancestors. Genes make up everything we are. One gets their traits from their parents. Most people live full lives with relatively good health. However, some people inherit mutated genes or faulty genes. This could lead to genetic disorders that could be life threatening. Even today, many genetic disorders still remain incurable, leaving many people without hope. Genetic therapy could be their answer. It is through this research that the cure for genetic disorders can be found. Though some people believe it is unethical or immoral to alter genes, current therapeutics have not been able to save the lives of the patients with these diseases. Genetic therapy